Apogem Secondary Fund VII Coinvestments, LP — Form D/A
Apogem Secondary Fund VII Coinvestments, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-10-07. $156.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-10-07
- Form: D/A
- Accession: 0002040612-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Amount sold: $156.6M
- Minimum investment: $1.0M
- Investors: 2
- Date of first sale: 2024-09-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-526524
Issuer
- Name: Apogem Secondary Fund VII Coinvestments, LP
- CIK: 0002040612
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 299 PARK AVENUE, NEW YORK, NY, 10171
- Phone: 212-601-3600
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| N/A ASF VII GP, LLC | Director | New York, NY |
| John M Grady | Executive Officer | New York, NY |
| Michael M Greich | Executive Officer | NEW YORK, NY |
| Christopher M Stringer | Executive Officer | New York, NY |
| Michael M Zeleniuch | Executive Officer | New York, NY |
| N/A M Apogem Capital LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More